Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN

Ryan Arthur F sold 100 Regeneron Pharmaceuticals, Inc. shares (Form 4)

Traded May 1, 2026 · Filed May 4, 2026

On May 1, 2026, Ryan Arthur F (Director) sold 100 Regeneron Pharmaceuticals, Inc. shares at an average US$705.24 for US$70,524 under a trading plan, leaving 17,503 shares. Filed May 4, 2026 (Form 4).

Sold
100 shares
Price
US$705.24 average (US$701.76 to US$714.13)
Value
US$70,524
Holding after
17,503 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 1, 2026Common StockSale5US$701.7617,598Direct
May 1, 2026Common StockSale15US$702.4617,583Direct
May 1, 2026Common StockSale24US$703.4617,559Direct
May 1, 2026Common StockSale15US$704.2817,544Direct
May 1, 2026Common StockSale14US$705.5617,530Direct
May 1, 2026Common StockSale7US$706.7417,523Direct
May 1, 2026Common StockSale4US$707.4017,519Direct
May 1, 2026Common StockSale6US$709.4517,513Direct
May 1, 2026Common StockSale2US$710.8717,511Direct
May 1, 2026Common StockSale5US$711.4917,506Direct
May 1, 2026Common StockSale1US$712.0917,505Direct
May 1, 2026Common StockSale2US$714.1317,503Direct

Source

View original at SEC

Related